Table 2.
References | Year | Period (years) | n | RI | Prevalence | Female prevalence | Male prevalence | Total incidence (per 100 PY) | 95% CI | Female prevalence (per 100 PY) | Male prevalence (per 100 PY) |
---|---|---|---|---|---|---|---|---|---|---|---|
Alves et al15 | 2003 | 4 | 350 | 36 (10.2%) | 7.10% | 5.10% | 9.10% | 2.00 | 1.1–3.5% | 1.20 | 2.70 |
de Freitas Oliveira et al16 | 2005 | 11 | 106 | 18 (17%) | NA | NA | 0.20 | 0.041–0.608% | NA | NA | |
Mercon et al17 | 2009 | 0.92 | 553 | 47 (8.5%) | 7.50% | NA | NA | 1.39 | 1.19–1.59% | NA | NA |
Bassichetto et al18 | 2009 | 0.50 | 194 | 29 (15%) | 3.20% | 2.1% | 4% | 0.53 | 0.31–0.85% | 0.22 | 0.53 |
de Castro et al19 | 2010 | 1 | 434 | 61 (14%) | 4.80% | NA | NA | 1.68 | 1.26–2.10% | NA | NA |
Lima et al20 | 2011 | 3 | 375 | 105 (28%) | 1310.00% | 0.87% | 2.80% | 1.31 | 0.61–0.86% | 0.55 | 1.34 |